JP2017536804A5 - - Google Patents

Download PDF

Info

Publication number
JP2017536804A5
JP2017536804A5 JP2017517301A JP2017517301A JP2017536804A5 JP 2017536804 A5 JP2017536804 A5 JP 2017536804A5 JP 2017517301 A JP2017517301 A JP 2017517301A JP 2017517301 A JP2017517301 A JP 2017517301A JP 2017536804 A5 JP2017536804 A5 JP 2017536804A5
Authority
JP
Japan
Prior art keywords
influenza
virus
amino acid
biologically active
polynucleotide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017517301A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017536804A (ja
JP6953308B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/053385 external-priority patent/WO2016054309A1/en
Publication of JP2017536804A publication Critical patent/JP2017536804A/ja
Publication of JP2017536804A5 publication Critical patent/JP2017536804A5/ja
Application granted granted Critical
Publication of JP6953308B2 publication Critical patent/JP6953308B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017517301A 2014-10-02 2015-10-01 インフルエンザa型ウイルスバリアント Expired - Fee Related JP6953308B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462058961P 2014-10-02 2014-10-02
US62/058,961 2014-10-02
PCT/US2015/053385 WO2016054309A1 (en) 2014-10-02 2015-10-01 Influenza a virus variants

Publications (3)

Publication Number Publication Date
JP2017536804A JP2017536804A (ja) 2017-12-14
JP2017536804A5 true JP2017536804A5 (https=) 2018-11-08
JP6953308B2 JP6953308B2 (ja) 2021-10-27

Family

ID=54293398

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017517301A Expired - Fee Related JP6953308B2 (ja) 2014-10-02 2015-10-01 インフルエンザa型ウイルスバリアント

Country Status (11)

Country Link
US (1) US10801076B2 (https=)
EP (1) EP3201220A1 (https=)
JP (1) JP6953308B2 (https=)
KR (1) KR20170063944A (https=)
CN (1) CN107002086B (https=)
AU (1) AU2015325012B2 (https=)
BR (1) BR112017006680A2 (https=)
CA (1) CA2963070A1 (https=)
MA (1) MA40772A (https=)
RU (1) RU2748618C2 (https=)
WO (1) WO2016054309A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT3141252T (lt) 2009-06-17 2018-11-12 Vertex Pharmaceuticals Inc. Gripo virusų replikacijos inhibitoriai
UA118010C2 (uk) 2011-08-01 2018-11-12 Вертекс Фармасьютікалз Інкорпорейтед Інгібітори реплікації вірусів грипу
JP6618901B2 (ja) 2013-11-13 2019-12-11 バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated インフルエンザウイルスの複製の阻害剤を調製する方法
LT3068776T (lt) 2013-11-13 2019-08-12 Vertex Pharmaceuticals Incorporated Gripo virusų replikacijos inhibitoriai
MA40773A (fr) 2014-10-02 2017-08-08 Vertex Pharma Variants du virus influenza a
EP3294717B1 (en) 2015-05-13 2020-07-29 Vertex Pharmaceuticals Inc. Methods of preparing inhibitors of influenza viruses replication
EP3294735B8 (en) 2015-05-13 2022-01-05 Vertex Pharmaceuticals Incorporated Inhibitors of influenza viruses replication
JP2021520363A (ja) * 2018-04-06 2021-08-19 ヤンセン ファーマシューティカルズ,インコーポレーテッド 結晶形態のピモジビル塩酸塩半水和物を調製するための等温反応性結晶化方法
US20200397784A1 (en) * 2019-06-20 2020-12-24 Janssen Pharmaceuticals, Inc. Formulations of azaindole compounds

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5843701A (en) 1990-08-02 1998-12-01 Nexstar Pharmaceticals, Inc. Systematic polypeptide evolution by reverse translation
ATE158021T1 (de) 1990-08-29 1997-09-15 Genpharm Int Produktion und nützung nicht-menschliche transgentiere zur produktion heterologe antikörper
DE69730157T2 (de) 1996-10-17 2005-07-28 Mitsubishi Chemical Corp. Molekül, welches genotyp und phänotyp zusammenführt und dessen anwendungen
ATE332368T1 (de) 1997-01-21 2006-07-15 Gen Hospital Corp Selektion von proteinen mittels rns-protein fusionen
ES2319864T3 (es) * 2000-04-28 2009-05-14 St. Jude Children's Research Hospital Sistema de transfeccion de adn para la generacion de virus infecciosos de arn de cadena negativa.
KR100894167B1 (ko) 2001-08-14 2009-04-22 토야마 케미칼 컴퍼니 리미티드 신규의 바이러스 증식저해 ·살바이러스방법 및 신규의피라진뉴클레오티드 ·피라진뉴클레오시드 유사체
ES2364340T3 (es) 2004-03-30 2011-08-31 Vertex Pharmaceuticals Incorporated Azaindoles útiles como inhibidores de jak y otras proteína quinasas.
WO2006050076A1 (en) 2004-10-29 2006-05-11 Janssen Pharmaceutica, N.V. Pyrimidinyl substituted fused-pyrrolyl compounds useful in treating kinase disorders
FI20060200A0 (fi) * 2005-04-20 2006-02-27 Glykos Finland Oy Menetelmä ihmisen influenssaviruksen sialihahappositoumisspesifisyyden analysoimiseksi
RU2387653C2 (ru) 2005-05-16 2010-04-27 Айрм Ллк Соединения и композиции в качестве ингибиторов протеинкиназ
KR20080047355A (ko) * 2005-07-06 2008-05-28 바이오칩 이노베이션즈 피티와이 리미티드 표적 핵산 서열 분석 방법 및 키트
KR100708593B1 (ko) 2006-03-23 2007-04-18 주식회사 고려비엔피 발육란 생산성이 우수한 저병원성 h9n2 아형 조류인플루엔자 바이러스
WO2009125395A1 (en) * 2008-04-09 2009-10-15 Technion Research & Development Foundation Ltd. Anti influenza antibodies and uses thereof
LT3141252T (lt) 2009-06-17 2018-11-12 Vertex Pharmaceuticals Inc. Gripo virusų replikacijos inhibitoriai
UA118010C2 (uk) * 2011-08-01 2018-11-12 Вертекс Фармасьютікалз Інкорпорейтед Інгібітори реплікації вірусів грипу
MA40773A (fr) 2014-10-02 2017-08-08 Vertex Pharma Variants du virus influenza a

Similar Documents

Publication Publication Date Title
JP2017536804A5 (https=)
JP2017537605A5 (https=)
Álvarez-Buylla et al. Identification of Acinetobacter species: is Bruker biotyper MALDI-TOF mass spectrometry a good alternative to molecular techniques?
Okomo‐Adhiambo et al. Assays for monitoring susceptibility of influenza viruses to neuraminidase inhibitors
EP2630239B1 (en) Kit for detecting bovine leukemia virus (blv), and use thereof
RU2017114675A (ru) Варианты вируса гриппа a
US20210292820A1 (en) Compositions and methods for detecting and treating sars-cov-2
Huang et al. Development of a PCR assay for diagnosis of Pneumocystis carinii pneumonia based on amplification of the multicopy major surface glycoprotein gene family
Cotroneo et al. Lung expression of genes putatively involved in SARS-CoV-2 infection is modulated in cis by germline variants
KR20230117152A (ko) 코로나바이러스 감염 발생 위험이 증가한 대상체의 식별 및 이의 치료 방법
JP7084034B2 (ja) 神経芽腫の微小残存病変を評価するために用いられる試薬、およびそれを用いた生体試料の分析方法
US20200216903A1 (en) Mitochondrial Disease Genetic Diagnostics
JPWO2020032228A5 (https=)
CN104313123B (zh) 一种结核分枝杆菌四种一线药物耐药基因特异片段组合及其应用
CN103540676B (zh) 一种检测线粒体基因1555位a-g与1494位c-t突变的试剂盒
RU2550257C2 (ru) СПОСОБ ДИФФЕРЕНЦИАЦИИ ТИПИЧНЫХ И АТИПИЧНЫХ ШТАММОВ Yersinia pestis СРЕДНЕВЕКОВОГО БИОВАРА МЕТОДОМ ПЦР С ГИБРИДИЗАЦИОННО-ФЛУОРЕСЦЕНТНЫМ УЧЕТОМ РЕЗУЛЬТАТОВ
CN116855637B (zh) 一种检测美洲鳗鲡腺瘤病毒的引物对和试剂盒
Doumayrou et al. Mapping genetic determinants of viral traits with FST and quantitative trait locus (QTL) approaches
RU2762236C1 (ru) Набор синтетических олигонуклеотидных праймеров для получения полной нуклеотидной последовательности гена vp1 энтеровируса коксаки а10
CN102925555A (zh) 定性检测人类braf v600e基因突变的测序引物对及其试剂盒
CN105316350B (zh) 结核分枝杆菌EmbB突变基因及其用途
JP4853898B2 (ja) Dna標準物質
Leisova‐Svobodova et al. Detection of Garlic Viruses Using SYBR Green Real‐time Reverse Transcription‐Polymerase Chain Reaction
Sahoo et al. Diversity of SARS-CoV-2 genome among various strain identified in Lucknow, Uttar Pradesh
Sahoo et al. Diversity of SARS-CoV-2 genome among various strains identified in Lucknow, Uttar Pradesh